Pliant Therapeutics, Inc. (PLRX)

Pliant Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	115.78	64.72	33.69	51.67	50.88	85.81
Short-Term Investments	368.09	431.01	297.5	148.93	226.01	16.97
Cash & Cash Equivalents	483.87	495.73	331.19	200.6	276.89	102.77
Cash Growth	-16.19%	49.68%	65.10%	-27.55%	169.42%	68.62%
Receivables	0	0	1.98	2	9.28	7.05
Other Current Assets	6.03	9.78	7.14	6.85	4.58	2.08
Total Current Assets	489.9	505.5	340.31	209.44	290.75	111.9
Property, Plant & Equipment	29.83	4.78	9.91	10.94	4.32	4.08
Other Long-Term Assets	1.87	1.87	0.39	0.84	0.45	3.09
Total Long-Term Assets	31.71	6.65	10.3	11.77	4.77	7.16
Total Assets	521.61	512.15	350.61	221.22	295.53	119.06
Accounts Payable	7.33	4.53	1.58	2.97	2.02	1.25
Current Debt	0.77	1.32	2.46	1.87	0	0
Other Current Liabilities	22.29	22.68	19.88	11.99	9.58	6.92
Total Current Liabilities	30.39	28.52	23.91	16.83	11.6	8.17
Long-Term Debt	53.88	10.05	13.36	5.33	0	0
Other Long-Term Liabilities	0	0	0	0	0.87	0.91
Total Long-Term Liabilities	53.88	10.05	13.36	5.33	0.87	0.91
Total Liabilities	84.27	38.58	37.27	22.16	12.47	9.08
Total Debt	54.66	11.37	15.82	7.19	0	0
Debt Growth	259.86%	-28.09%	119.84%	-	-	-
Retained Earnings	-546.7	-499.75	-338.41	-215.09	-117.83	-76.3
Comprehensive Income	-0.49	0.35	-1.96	-0.2	-0.03	-0
Shareholders' Equity	437.33	473.58	313.34	199.06	283.06	-76.3
Net Cash / Debt	429.22	484.36	315.37	193.4	276.89	102.77
Net Cash / Debt Growth	-23.64%	53.58%	63.07%	-30.15%	169.42%	68.62%
Net Cash Per Share	7.13	8.25	7.51	5.40	12.97	63.31
Working Capital	459.51	476.98	316.4	192.61	279.16	103.73
Book Value Per Share	7.27	8.06	7.46	5.55	13.26	-47.00

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).